Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra

We report the case of a 63-year-old male diagnosed with chronic autoimmune mediated meningoencephalitis and periodic cyclical fever syndrome. After 2 years of failed conventional treatment and recurrent hospitalizations, anakinra treatment (an interleukin-1 [IL-1] receptor antagonist) was trialed wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Novroski, Alyssa-Rae, Baldwin, Kelly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437444/
https://www.ncbi.nlm.nih.gov/pubmed/28559832
http://dx.doi.org/10.1159/000472147
_version_ 1783237589862449152
author Novroski, Alyssa-Rae
Baldwin, Kelly J.
author_facet Novroski, Alyssa-Rae
Baldwin, Kelly J.
author_sort Novroski, Alyssa-Rae
collection PubMed
description We report the case of a 63-year-old male diagnosed with chronic autoimmune mediated meningoencephalitis and periodic cyclical fever syndrome. After 2 years of failed conventional treatment and recurrent hospitalizations, anakinra treatment (an interleukin-1 [IL-1] receptor antagonist) was trialed which resulted in full recovery. As evidenced by this case, anakinra can be used to treat chronic autoimmune meningitis, which can often be refractory to treatment.
format Online
Article
Text
id pubmed-5437444
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54374442017-05-30 Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra Novroski, Alyssa-Rae Baldwin, Kelly J. Case Rep Neurol Case Report We report the case of a 63-year-old male diagnosed with chronic autoimmune mediated meningoencephalitis and periodic cyclical fever syndrome. After 2 years of failed conventional treatment and recurrent hospitalizations, anakinra treatment (an interleukin-1 [IL-1] receptor antagonist) was trialed which resulted in full recovery. As evidenced by this case, anakinra can be used to treat chronic autoimmune meningitis, which can often be refractory to treatment. S. Karger AG 2017-05-05 /pmc/articles/PMC5437444/ /pubmed/28559832 http://dx.doi.org/10.1159/000472147 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Novroski, Alyssa-Rae
Baldwin, Kelly J.
Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title_full Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title_fullStr Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title_full_unstemmed Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title_short Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
title_sort chronic autoimmune meningoencephalitis and periodic fever syndrome treated with anakinra
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437444/
https://www.ncbi.nlm.nih.gov/pubmed/28559832
http://dx.doi.org/10.1159/000472147
work_keys_str_mv AT novroskialyssarae chronicautoimmunemeningoencephalitisandperiodicfeversyndrometreatedwithanakinra
AT baldwinkellyj chronicautoimmunemeningoencephalitisandperiodicfeversyndrometreatedwithanakinra

Ejemplares similares